{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:52:11Z","timestamp":1786373531084,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,10]]},"abstract":"\n Background and objectives<\/jats:title>\n Idiopathic collapsing FSGS has historically been associated with poor renal outcomes. Minimal clinical data exist on the efficacy of immunosuppressive therapy. Our study sought to provide a comprehensive description of renal survival in patients with collapsing and not otherwise specified FSGS after controlling for factors affecting renal prognosis.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n We performed a retrospective analysis of an inception cohort study of patients diagnosed between 1989 and 2012. All potential patients with collapsing FSGS fulfilling the inclusion criteria were identified and compared with patients with not otherwise specified FSGS (approximately 1:2 ratio) on the basis of biopsy report and record availability. Time to ESRD was analyzed using Cox proportional hazards models.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In total, 187 patients were studied (61 collapsing and 126 not otherwise specified), with a mean follow-up of 96 months. At baseline, patients with collapsing FSGS had higher median proteinuria (12.2 [5.6\u201314.8] versus 4.4 [2.3\u20138.1] g\/d, respectively;\n P<\/jats:italic>\n <0.001), lower median albuminemia (2.4 [1.9\u20133.0] versus 2.9 [1.8\u20133.7] g\/dl, respectively;\n P<\/jats:italic>\n =0.12), and lower median eGFR (48 [26\u201373] versus 60 [42\u201392] ml\/min per 1.73 m\n 2<\/jats:sup>\n , respectively;\n P<\/jats:italic>\n =0.01) than patients with not otherwise specified FSGS. The proportion of patients with remission of proteinuria was similar in patients with collapsing FSGS and patients with not otherwise specified FSGS (65.7% [23 of 35] versus 63.2% [72 of 114], respectively;\n P<\/jats:italic>\n =0.84). The overall renal outcome (ESRD defined as eGFR<15 ml\/min per 1.73 m\n 2<\/jats:sup>\n , dialysis, or transplantation) of patients with collapsing FSGS was not poorer than that of patients with not otherwise specified FSGS in multivariate analyses after adjusting for baseline characteristics and immunotherapy (hazard ratio, 1.78; 95% confidence interval, 0.92 to 3.45).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Compared with not otherwise specified FSGS, idiopathic collapsing FSGS presented with more severe nephrotic syndrome and lower eGFR but had a similar renal survival after controlling for exposure to immunosuppressive treatment. These results highlight the importance of early diagnosis and institution of immunosuppressive therapy in patients with collapsing FSGS.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.13091215","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T21:53:53Z","timestamp":1469138033000},"page":"1752-1759","source":"Crossref","is-referenced-by-count":48,"title":["Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS"],"prefix":"10.2215","volume":"11","author":[{"given":"Louis-Philippe","family":"Laurin","sequence":"first","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"},{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil M.","family":"Gasim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal K.","family":"Derebail","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JulieAnne G.","family":"McGregor","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"},{"name":"Triangle Integrative Medicine Associates, Chapel Hill, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Kidd","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"},{"name":"Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Hogan","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Poulton","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal K.","family":"Detwiler","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Charles","family":"Jennette","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Falk","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Nachman","sequence":"additional","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997.","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.","volume":"44","author":"Kitiyakara","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis.","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ki.1994.185","article-title":"Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis.","volume":"45","author":"Detwiler","year":"1994","journal-title":"Kidney Int"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2012040389","article-title":"Treatment of primary FSGS in adults.","volume":"23","author":"Korbet","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/ki.1996.493","article-title":"Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study.","volume":"50","author":"Valeri","year":"1996","journal-title":"Kidney Int"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants.","volume":"15","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","article-title":"Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2215\/CJN.06100612","article-title":"Association of histologic variants in FSGS clinical trial with presenting features and outcomes.","volume":"8","author":"D\u2019Agati","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/snep.2003.50012","article-title":"Pathologic classification of focal segmental glomerulosclerosis.","volume":"23","author":"D\u2019Agati","year":"2003","journal-title":"Semin Nephrol"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: A working proposal.","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0272-6386(86)80052-X","article-title":"Nephrotic syndrome, progressive irreversible renal failure, and glomerular \u201ccollapse\u201d: A new clinicopathologic entity?","volume":"7","author":"Weiss","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.00660113","article-title":"Histologic classification of FSGS: Does form delineate function?","volume":"8","author":"Choi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1681\/ASN.V1091900","article-title":"Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion.","volume":"10","author":"Schwartz","year":"1999","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201610000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:40Z","timestamp":1786369600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201610000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.13091215","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}